Files in this item

FilesDescriptionFormat

application/pdf

application/pdfSSRN-id2779965.pdf (139kB)
(no description provided)PDF

Description

Title:Describing Drugs: A Response to Profs. Allison and Ouellette
Author(s):Sherkow, Jacob S.
Subject(s):patents
intellectual property
ip
PTO
drugs
pharmaceuticals
bioscience
biotechnology
law
Allison
Ouellette
written description
112
empirical
doctrinal
Abstract:Profs. Allison and Ouellette’s Article, How Courts Adjudicate Patent Definiteness and Disclosure, 65 Duke L.J. 609 (2015), on courts’ adjudication of certain patent disputes presents some surprising data: pharmaceutical patents litigated to judgment fare substantially worse on written-description analyses if they are not part of traditional pioneer-generic litigation. This Response engages in several hypotheses for this disparity and examines the cases that make up Allison and Ouellette’s dataset. An analysis of these cases finds that the disparity can be best explained by technological and judicial idiosyncrasies in each case, rather than larger differences among pharmaceutical patent cases. This finding contextualizes the power and limits of large-scale empirical patent scholarship, like Allison and Ouellette’s, and provides of model for how empirical and doctrinal patent scholarship can complement one another.
Issue Date:2016-03-23
Publisher:Duke University Law Journal
Citation Info:Jacob S. Sherkow, Describing Drugs: A Response to Professors Allison and Ouellette, 65 Duke L.J. Online 127 (2016)
Genre:Article
Type:Text
Language:English
URI:http://hdl.handle.net/2142/110298
Date Available in IDEALS:2021-08-11


This item appears in the following Collection(s)

  • Illinois Research and Scholarship
    This is the default collection for all research and scholarship developed by faculty, staff, or students at the University of Illinois at Urbana-Champaign

Item Statistics